{{Drugbox
| Verifiedfields = 
| Watchedfields = 
| verifiedrevid = 
| IUPAC_name = 5-Chloro-1,3-benzoxazol-2-amine
| image = Zoxazolamine.svg
| width = 200px

<!--Clinical data-->
| tradename = 
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = 
| legal_UK = 
| legal_US = 
| legal_status = 
| routes_of_administration = [[Oral administration|Oral]]

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion =

<!--Identifiers-->
| CAS_number_Ref = 
| CAS_number = 61-80-3
| ChEBI = 35053
| ChEMBL = 472566
| CAS_supplemental = 
| ATC_prefix = 
| ATC_suffix = 
| PubChem = 6103
| DrugBank_Ref = 
| DrugBank = 
| UNII = 9DOW362Q29
| KEGG = C13841
| ChemSpiderID_Ref = 
| ChemSpiderID      = 5878

<!--Chemical data-->
| C=7 | H=5 | Cl=1 | N=2 | O=1
| molecular_weight = 168.5804 g/mol
| smiles = C1=CC2=C(C=C1Cl)N=C(O2)N
| StdInChI_Ref = 
| StdInChI = InChI=1S/C7H5ClN2O/c8-4-1-2-6-5(3-4)10-7(9)11-6/h1-3H,(H2,9,10)
| StdInChIKey_Ref = 
| StdInChIKey = YGCODSQDUUUKIV-UHFFFAOYSA-N
| synonyms = McN-485
}}

'''Zoxazolamine''' ([[International Nonproprietary Name|INN]], [[United States Adopted Name|USAN]], [[British Approved Name|BAN]]) (brand name '''Contrazole''', '''Deflexol''', '''Flexin''', '''Miazol''', '''Uri-Boi''', '''Zoxamine''', '''Zoxine''') is a [[muscle relaxant]] that is no longer marketed.<ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA48|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=48–}}</ref><ref name="Kar2005">{{cite book|author=Ashutosh Kar|title=Medicinal Chemistry|url=https://books.google.com/books?id=07g30rxCA0EC&pg=PA185|date=1 January 2005|publisher=New Age International|isbn=978-81-224-1565-0|pages=185–}}</ref> It was synthesized in 1953 and introduced clinically in 1955 but was [[list of withdrawn drugs|withdrawn]] due to [[hepatotoxicity]].<ref name="Elks2014" /><ref name="Kar2005" /><ref name="Lowry2012">{{cite book|author=W. Lowry|title=Forensic Toxicology: Controlled Substances and Dangerous Drugs|url=https://books.google.com/books?id=szDnBwAAQBAJ&pg=PA166|date=6 December 2012|publisher=Springer Science & Business Media|isbn=978-1-4684-3444-6|pages=166–}}</ref> One of its [[active metabolite]]s, [[chlorzoxazone]], was found to show less toxicity, and was subsequently marketed in place of zoxazolamine.<ref name="Lowry2012" /> These drugs activate [[IK channel|IK<sub>Ca</sub> channel]]s.<ref name="Offermanns">{{cite book|author=Stefan Offermanns|title=Encyclopedia of Molecular Pharmacology|url=https://books.google.com/books?id=iwwo5gx8aX8C&pg=PA996|publisher=Springer Science & Business Media|isbn=978-3-540-38916-3|pages=996–}}</ref>

==References==
{{Reflist|2}}


{{Muscle relaxants}}
{{Ion channel modulators}}

[[Category:Amines]]
[[Category:Benzoxazoles]]
[[Category:Hepatotoxins]]
[[Category:Muscle relaxants]]
[[Category:Organochlorides]]
[[Category:Withdrawn drugs]]


{{musculoskeletal-drug-stub}}